Exonate
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.

Profile
Exonate’s research in this area has identified therapeutic candidates for wet Age Related Macular Degeneration that can be administered as a simple eye drop, thereby over-coming the unpleasant need for monthly injections in the eye.
Competing injectable anti-VEGFdirected therapy currently constitutes the gold-standard treatment for wet Age Related Macular Degeneration (wAMD) and other neovascular diseases of the eye.
News and press releases
First patient dosed with a new eye drop to treat one of the leading causes of blindness
- 2nd February 2021 1:46 pm·
CognitOss Granted FDA Breakthrough Device Designation
- 7th January 2021 3:37 pm·
Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors
- 7th January 2021 3:31 pm·
New spin-out company signals quantum leap for brain imaging
- 8th December 2020 12:54 pm·
UK wide study aims to relieve millions who suffer from dry eye syndrome
- 7th October 2020 4:29 pm·
Eye-sight saving tech designed by Nottingham healthcare experts could help cut post-Covid NHS waiting lists
- 1st September 2020 11:44 am·
EventMAP software implementation helps NHS Foundation Trust staff return to work
- 30th July 2020 10:39 am·
Promethean Particles Wins Prestigious Institute of Physics Award
- 27th July 2020 11:36 am·
Locate Bio raises £2.25m for new spinal treatments
- 22nd July 2020 4:37 pm·
SurePulse lands £1m investment to expand its share of neonatal healthtech market
- 16th July 2020 5:05 pm·
University of Nottingham generates £1.5m from the sale of Oncimmune shares
- 15th June 2020 4:50 pm·
Scancell to initiate development of novel DNA vaccine against COVID-19
- 20th May 2020 3:35 pm·
@ExonateUK on Twitter
Today we announced results from the US Phase III clinical trial for our COVID-19 vaccine candidate, which demonstrated high efficacy in preventing #COVID19, with no severe cases or hospitalizations. https://bit.ly/3f6PlBM
Happy World Optometry Day !
#Optometry,.. #worldoptometryday
@SeeChange4all
👓 Today the world celebrates #WorldOptometryDay!
To mark the day - book your next sight test! Optometrists advise to get a test every two years.
👉 Visit this page from @FredHollows to find out what you should expect from an eye test.
http://ow.ly/P2pA50E5DVQ
Happy World Optometry Day 2021: Celebrating optometrists! - To mark the day, we bring you stories on how optometry has evolved over the years, its expanding scope of practice in the US & more... https://mailchi.mp/iapb.org/world-optometry-day2021-2626472
📈 It is projected that by 2050 half of the world’s population will be myopic.
The response to this public health challenge has to be led by #Optometry, writes Kovin Naidoo ... #worldoptometryday @SeeChange4all
https://www.iapb.org/blog/myopia-a-public-health-challenge-that-demands-optometrys-leadership/
We are excited to announce that Exonate’s Principal Scientist Dr. Jenny Batson will be presenting at the ‘Women in Leadership: Career Insights from Industry and Academia’, seminar.
https://sruk.org.uk/events/women-in-leadership-career-insights-from-industry-and-academia #IWD2021
Join us to celebrate #science and #InternationalWomensMonth !
TOMORROW, at 7 pm (GMT), Dr Jennifer Batson (@JennyBatson), principal scientist at @ExonateUK will be sharing her journey and knowledge on #drugdiscovery 👁️👩🔬
Secure your place here ➡️ http://ow.ly/WTmF30rzu5M
We are pleased to announce the launch of a research use only molecular test to aid in the public health management of emerging #coronavirus #variants. https://go.roche.com/MR_CV $ROG $RHHBY #Media